Cargando…

The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review

SIMPLE SUMMARY: In patients with advanced ovarian cancers, the standard first-line treatment includes debulking surgery and platinum-based chemotherapy, followed by a maintenance treatment. Contrary to the completeness of the debulking surgery, the prognostic impact of the tumor chemosensitivity in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lauby, Ambroise, Colomban, Olivier, Corbaux, Pauline, Peron, Julien, Van Wagensveld, Lilian, Gertych, Witold, Bakrin, Naoual, Descargues, Pierre, Lopez, Jonathan, Kepenekian, Vahan, Glehen, Olivier, Philip, Charles Andre, Devouassoux-Shisheboran, Mojgan, Tod, Michel, Freyer, Gilles, You, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750686/ https://www.ncbi.nlm.nih.gov/pubmed/35008262 http://dx.doi.org/10.3390/cancers14010098

Ejemplares similares

Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer
por: Bhatt, Aditi, et al.
Publicado: (2022)

Front-Line Maintenance Therapy in Advanced Ovarian Cancer—Current Advances and Perspectives
por: Reverdy, Thibaut, et al.
Publicado: (2020)

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study
por: You, Benoit, et al.
Publicado: (2022)

Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10
por: Colomban, Olivier, et al.
Publicado: (2023)

Epidemiology of psychiatric disorders following cytoreductive surgeries plus hyperthermic intraperitoneal chemotherapy: a prospective cohort analysis
por: Economos, Guillaume, et al.
Publicado: (2023)

Polypoid endometriosis of the Douglas pouch
por: Jacquot, A, et al.
Publicado: (2020)

Pathobiology of ovarian carcinomas
por: Devouassoux-Shisheboran, Mojgan, et al.
Publicado: (2015)

Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival
por: Kepenekian, Vahan, et al.
Publicado: (2022)

Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)
por: Colomban, Olivier, et al.
Publicado: (2020)

Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses
por: Souadka, Amine, et al.
Publicado: (2022)

Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study
por: Alejandra, Martinez, et al.
Publicado: (2021)

Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) vs CRS alone for treatment of endometrial cancer with peritoneal metastases: a multi-institutional study from PSOGI and BIG RENAPE groups
por: Gomes David, Manuel, et al.
Publicado: (2022)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer
por: Hamizi, Salima, et al.
Publicado: (2013)

Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study
por: Dumont, Frédéric, et al.
Publicado: (2023)

CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study
por: You, Benoit, et al.
Publicado: (2023)

Developing a core set of patient-reported outcomes and patient-reported experience measures for peritoneal surface malignancies (COMETE)
por: Taibi, Abdelkader, et al.
Publicado: (2023)

Prise en charge des tumeurs primitives et métastatiques du péritoine en période de pandémie CoViD-19. Pistes de réflexion et de priorisation du groupe RENAPE et BIG-RENAPE()
por: Glehen, O., et al.
Publicado: (2020)

Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups
por: Glehen, O., et al.
Publicado: (2020)

Diagnostic yield and therapeutic impact of open lung biopsy in the critically ill patient
por: Philipponnet, Carole, et al.
Publicado: (2018)

Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients
por: Kefleyesus, Amaniel, et al.
Publicado: (2023)

HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments
por: Essadi, Ismail, et al.
Publicado: (2023)

Prediction of tumour response induced by chemotherapy using modelling of CA-125 kinetics in recurrent ovarian cancer patients
por: Wilbaux, M, et al.
Publicado: (2014)

Technique of pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural effusion
por: Drevet, Gabrielle, et al.
Publicado: (2020)

Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study
por: Cashin, Peter H., et al.
Publicado: (2022)

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO
por: Bengrine, Leila, et al.
Publicado: (2022)

Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era
por: You, Benoit, et al.
Publicado: (2022)

Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel
por: Carrot, Aurore, et al.
Publicado: (2022)

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?
por: Gouy, Sebastien, et al.
Publicado: (2017)

The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells()
por: Jacqueroud, Laurent, et al.
Publicado: (2016)

Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types
por: Gouy, Sebastien, et al.
Publicado: (2017)

Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer
por: Breusa, Silvia, et al.
Publicado: (2023)

Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
por: Bourmaud, Aurélie, et al.
Publicado: (2015)

Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer
por: Drouet, Youenn, et al.
Publicado: (2018)

Predictive factors for severe placental damage in pregnant women with SARS-CoV-2 infection
por: Damman, Elise, et al.
Publicado: (2023)

CREB fusion–associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype
por: Trecourt, Alexis, et al.
Publicado: (2023)

Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL)
por: Belmont, Anne-Sophie, et al.
Publicado: (2021)

Early Preinvasive Lesions in Ovarian Cancer
por: Chene, Gautier, et al.
Publicado: (2014)

Characterization of Lung Inflammatory Response to Aspergillus fumigatus Spores
por: Bouyssi, Alexandra, et al.
Publicado: (2023)

Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
por: Auguste, Aurélie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ogkmibrci85vvnb5u4iv7j1jd4